Furthermore, disparities in CpG methylation within the CXXC5 promoter were identified in prostate, bladder, and thyroid cancers compared to normal tissues, indicating that methylation may play a role in regulating CXXC5 expression [41–43]. This evidence concerns the gene CXXC5 and thyroid gland carcinoma.